Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
批准号:
10033650
负责人:
Yang Zhou
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-25 至 2024-07-31
关键词:
AffectBiological AssayCalciumCardiacCardiac MyocytesCell MaturationCellsChromatinCicatrixComputer AnalysisDataDermalDeveloped CountriesDevelopmentFamilyFibroblastsFutureGene ActivationGene Expression ProfilingGenerationsGenesGeneticGenetic TranscriptionGenomicsHeartHeart failureHistonesHumanImageIn SituIn VitroInjuryIntercellular JunctionsIon ChannelLeftMembraneMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardial IschemiaMyofibrilsNatural regenerationNeonatalOpticsPatientsPerformancePlayProcessRegulationReportingResearchResidual stateRoleRouteSarcomeresStructureSystemTechnologyTestingTherapeuticTimeTissuesTransactivationTransmission Electron Microscopybasecardiac repairclinical applicationclinical translationcofactorepigenomicsgenetic signaturein vivoinducible gene expressioninjuredinsightloss of functionmortalitymultiple omicsnoveloverexpressionpenis foreskinprogramsprotein expressionsingle-cell RNA sequencingstem cell differentiationtranscription factortranscriptometranscriptomicstreatment strategytumorigenesisvoltage
中文摘要
摘要
从成纤维细胞直接对诱导的心肌细胞(ICM)进行心脏重编程已成为一种
治疗心力衰竭的有希望的治疗策略,心力衰竭仍然是死亡和死亡的主要原因
发达国家的发病率。虽然关于从小鼠细胞产生的ICM已知很多,但
直接心脏重编程适应人类细胞的效率和质量都很低
因为物种之间的内在差异。我们最近报道了单细胞转录分析
在人类心脏重新编程期间,发现ICM的生成不足与
与不发达的基因程序,如离子通道和细胞连接,表明额外的
可能需要重新编程调节心肌细胞功能的因子。在这个研究项目中,我们
一种新的重编程因子TBX20在产生心肌细胞特性中起重要作用的假说
通过建立与心肌细胞功能相关的基因程序。为了支持我们的假设,我们的
初步数据显示,在人类ICM中,TBX20在很大程度上表达不足。虽然强迫表达
在激活基因程序的同时,显著提高了重编程效率
与心肌细胞功能有关。为了检验这一假设,我们建议1)进一步确定影响
TBX20对人类心脏直接重编程的影响和2)确定TBX20如何作为必需的
在这一过程中的重新编程因素。这项建议的主要目标是确定
Tbx20对心脏直接重编程过程中心肌细胞再生的影响。这项工程的完成
该提案不仅提供了对心肌细胞身份如何通过直接
心脏重新编程,也使我们能够直接从人类产生功能可靠的心肌细胞
非心肌细胞用于潜在的心脏修复。
英文摘要
SUMMARY
Direct cardiac reprogramming to generated induced cardiomyocytes (iCMs) from fibroblasts has emerged as a
promising therapeutic strategy for the treatment of heart failure, which is still the leading cause of mortality and
morbidity in the developed country. While much is known regarding iCMs generated from mouse cells, the
adaptation of direct cardiac reprogramming to human cells is hurdled with low efficiency and poor quality
because of intrinsic differences between species. We recently reported the single cell transcriptomic analysis
during human cardiac reprogramming and discovered that the insufficient generation of iCMs is associated
with underdeveloped gene programs, such as ion channel and cell junction, suggesting that additional
reprogramming factors regulating function of cardiomyocytes might be required. In this research program, we
hypothesis that a novel reprogramming factor TBX20 plays an essential role to generate cardiomyocyte identity
by establishing gene programs associated with cardiomyocyte function. In support of our hypothesis, our
preliminary data have shown that TBX20 is largely under-expressed in human iCMs. While forced expression
of TBX20 significantly enhanced reprogramming efficiency accompanied with activation of gene programs
associated with cardiomyocyte function. To test the hypothesis, we propose to 1) further determine the impact
of TBX20 on direct human cardiac reprogramming and 2) determine how TBX20 functions as an essential
reprogramming factor during this process. The main objective of this proposal is to identify the critical role of
TBX20 on regeneration of cardiomyocytes during direct cardiac reprogramming. The completion of this
proposal will not only provide mechanistic insight into how cardiomyocyte identity can be regenerated by direct
cardiac reprogramming but also enable us to generate functional-reliable cardiomyocytes directly from human
non-myocytes for potential heart repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10850273
-
项目类别:
-
资助金额:$4.47万
-
财政年份:2023
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10554375
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10355479
-
项目类别:
-
资助金额:$40.43万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:9887633
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10662347
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10455734
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10245150
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:10437834
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2013
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:10200080
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2013
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:9573405
-
项目类别:
-
资助金额:$25.63万
-
财政年份:--
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:9979904
-
项目类别:
-
资助金额:$23.52万
-
财政年份:--
-
负责人:Yang Zhou
-
依托单位:
海外基金